pimagedine has been researched along with Retinal Neovascularization in 1 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
Retinal Neovascularization: Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Q | 1 |
| Zhang, J | 1 |
| Guan, Y | 1 |
| Zhang, S | 1 |
| Zhu, C | 1 |
| Xu, GT | 1 |
| Wang, L | 1 |
1 other study available for pimagedine and Retinal Neovascularization
| Article | Year |
|---|---|
Suppression of retinal neovascularization by the iNOS inhibitor aminoguanidine in mice of oxygen-induced retinopathy.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Antibodies, Monoclonal; Antibodies, Monoclonal, | 2009 |